Securities and Exchange Commission v. Nutra Pharma Corporation et al

  1. March 15, 2024

    'Cobra Venom' Painkiller Co. Inks Deal To Settle SEC Claims

    A penny stock company that previously held itself out as a maker of cobra venom-infused pain drugs has agreed to resolve U.S. Securities and Exchange Commission fraud claims, according to court filings that note the company's two principals have also reached a settlement.

  2. April 01, 2020

    Promoter Disclosed 'Cobra Venom' Co. Payment, Judge Says

    A federal judge in New York on Tuesday trimmed allegations concerning a pay-for-play stock promoter from a suit alleging a Florida company misrepresented that it made cobra venom pain relievers.

  3. September 28, 2018

    SEC Accuses Drugmaker of Venomous Deceptions

    A Florida-based microcap securities issuer that claimed to make pain relievers with cobra venom is accused by the U.S. Securities and Exchange Commission in a civil complaint filed Friday of misleading investors by claiming, among other things, that it was distributing its product internationally when it was not.